aTyr Pharma, Inc. LIFE · Stock Open aTyr Pharma, Inc. in new tab
aTyr Pharma, Inc. Analysis (LIFE)
Is aTyr Pharma, Inc. a good investment? aTyr Pharma, Inc. (LIFE) is currently trading at 22.83 USD. Market analysts have a consensus price target of 27.43 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 26.10. This valuation is generally in line with the broader market.
Earnings Schedule: aTyr Pharma, Inc. is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 1.93.
Investor FAQ
Does aTyr Pharma, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is aTyr Pharma, Inc.?
aTyr Pharma, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of -1.71.
Company Profile
Ethos Technologies Inc. provides third-party administrator services for insurance policies in the United States. The company offers Ethos, a three-sided technology platform that serves an ecosystem of consumers, agents, and carriers. It also provides term life insurance, whole life insurance, and indexed universal life insurance products, as well as wills and estate planning, and supplemental health insurance products. The company was formerly known as Ethos Insurance Corporation and changed its name to Ethos Technologies Inc. in August 2016. The company was incorporated in 2016 and is based in San Francisco, California.
Community Discussion